UDST Hosts Successful International Conference on Drug Discovery, Development 

 

 

Doha, October 24 (QNA) - University of Doha for Science and Technology (UDST) recently hosted the International Conference on in silico Trends and Approaches in Drug Discovery and Development, sponsored by the Qatar National Research Fund, under the Qatar Research Development and Innovation Council. 

The three-day conference was an important forum for knowledge exchange among researchers, academics, students, and industry professionals. The event showcased contemporary ideas and tools for in-silico drug discovery and development.

Dr. Salem Al Naemi, the President of UDST officially opened the conference in the presence of representatives from Qatar Research, Development, and Innovation (QRDI), Sidra Medicine, and with the participation of the World Health Organization (WHO) and many institutions. The conference featured multiple keynote speakers from different parts of the world, each an expert in pharmacology, pharmaceutical sciences, and bioinformatics, covering an array of current topics.

During his opening speech, Dr. Salem Al Naemi said: "By bringing together diverse expertise in the field of in-silico pharmacology, this conference helps push the boundaries of drug discovery and development research within the context of education. The conference, being hosted at UDST, underscores our commitment to support, and be part of, pivotal scientific discussions and developments, and it also represents the University’s integral role in fostering an environment for scientific innovation and dialogue."

"Sponsoring the International Conference on in silico Trends & Approaches in Drug Discovery and Development at UDST is not just an honour, it's a testament to our unwavering commitment to pushing the boundaries of in silico pharmacology and drug discovery & development research and education. This conference signifies a pivotal moment for Qatar, where we consolidate our position as leaders in these critical fields. We extend our heartfelt gratitude to all participants for being part of this groundbreaking event, where innovation, education, and inclusivity converge to craft a brighter, more promising future. Your presence exemplifies the collaborative spirit and dedication that fuels our collective pursuit of knowledge and progress." said Dr. Hisham M. Sabir, Executive Director of QNRF Program Office, Qatar Research, Development, and Innovation (QRDI) Council.

Dr. Rayana Bou Haka, WHO Representative in the State of Qatar said: "The promising contributions to the Global public of pharmacogenomics open new domains for working on scientific innovations while highlighting the importance of networking and knowledge sharing."

The conference witnessed more than 300 individual registrations and featured more than 50 accepted abstracts from different parts of the world.

Attendees navigated complex topics within computational biology, exploring and debating the potentials and challenges of the recent trend, applying artificial intelligence and machine learning to drug discovery. The conference also offered a comprehensive look at the practical and academic implications of in-silico approaches in pharmacology education, providing participants with fresh perspectives and insights. (QNA)